New approach for cancer patients whose bleeding Won't stop
NCT ID NCT05091684
Summary
This study tested whether giving fibrinogen concentrate could help control bleeding in cancer patients undergoing chemotherapy who don't respond to standard platelet transfusions. Researchers measured how well blood clots formed before and after treatment using special tests. The trial was terminated early after enrolling only one participant.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BLEEDING are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
CHU de Saint-Etienne
Saint-Etienne, 42055, France
Conditions
Explore the condition pages connected to this study.